The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol

24 Feb 20264 min read0 viewsJournal Feed

GIST

Annals of Internal Medicine, Volume 179, Issue 4 , Page 515-523, April 2026.

Clinical Editorial

Summary

Annals of Internal Medicine (ACP) published a clinical update in Research Highlights on 24 Feb 2026. The item focuses on The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol. Open the detail page to review the full original feed content.